Fresenius Medical Care (FMS) Expected to Announce Earnings on Tuesday

Fresenius Medical Care (NYSE:FMS) is expected to be posting its Q1 2025 quarterly earnings results before the market opens on Tuesday, May 6th. Analysts expect Fresenius Medical Care to post earnings of $0.45 per share and revenue of $4.71 billion for the quarter.

Fresenius Medical Care Stock Performance

NYSE:FMS opened at $25.62 on Monday. Fresenius Medical Care has a twelve month low of $17.93 and a twelve month high of $26.04. The company has a market cap of $15.03 billion, a P/E ratio of 21.17, a P/E/G ratio of 0.76 and a beta of 0.85. The company has a current ratio of 1.37, a quick ratio of 1.02 and a debt-to-equity ratio of 0.42. The company’s 50-day moving average price is $24.15 and its 200-day moving average price is $23.22.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the company. StockNews.com upgraded Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, February 5th. Truist Financial lifted their price target on Fresenius Medical Care from $23.00 to $25.00 and gave the stock a “hold” rating in a report on Monday, January 6th.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.